摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxamide | 104748-69-8

中文名称
——
中文别名
——
英文名称
3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxamide
英文别名
3-(cyanomethyl)-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-4-carboxamide
3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxamide化学式
CAS
104748-69-8
化学式
C11H14N4O5
mdl
——
分子量
282.256
InChiKey
JDXNBNWVISLXMV-TURQNECASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.8
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    155
  • 氢给体数:
    4
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxamide 在 sodium carbonate 作用下, 以 乙醇 为溶剂, 反应 0.5h, 以75%的产率得到6-amino-2-β-D-ribofuranosylpyrazolo<4,3-c>pyridin-4(5H)-one
    参考文献:
    名称:
    通过吡唑核苷前体的闭环合成6-氨基吡唑并[4,3 - c ]吡啶-4(5 H)-one的β-D-核糖-和2'-脱氧-β-D-核糖呋喃糖基衍生物
    摘要:
    6-氨基-1-(2-脱氧-β-D-氨基-呋喃呋喃糖基)吡唑并[4,3 - c ]吡啶-4(5 H)-一(5)以及2-(β-D-合成了6-氨基吡唑并[4,3 - c ]吡啶-4(5 H)-一(分别为18和22)的核糖呋喃糖基)-和2-(2-脱氧-β-D-核呋喃糖基)-衍生物。吡唑核苷前体的碱催化的闭环反应。甲基3(5)-cyanomethylpyrazole -4-羧酸乙酯(的钠盐的糖基化6与1-氯-2-脱氧-3,5-二- )ø - p甲苯甲酰-α-D-赤-pentofuranose(8)提供了相应的N-1和N-2糖基衍生物(分别为9和10)。用甲醇钠对9和10进行脱苯甲酰化,分别得到去保护的核苷14和16。14和16的进一步氨解得到5(或3)-氰基甲基-1-(2-脱氧-β-D-赤型-五呋喃糖基)吡唑-4-羧酰胺(分别为15和17)。在碳酸钠存在下15和17的闭环反应得到5和22, 分别。相比之下,钠盐的糖基化6与2
    DOI:
    10.1002/jhet.5570230112
  • 作为产物:
    描述:
    2,3,5-tri-O-benzoyl-β-D-ribofuranosyl bromide 、 sodium hydride 作用下, 以 甲醇 为溶剂, 反应 19.5h, 生成 3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxamide
    参考文献:
    名称:
    通过吡唑核苷前体的闭环合成6-氨基吡唑并[4,3 - c ]吡啶-4(5 H)-one的β-D-核糖-和2'-脱氧-β-D-核糖呋喃糖基衍生物
    摘要:
    6-氨基-1-(2-脱氧-β-D-氨基-呋喃呋喃糖基)吡唑并[4,3 - c ]吡啶-4(5 H)-一(5)以及2-(β-D-合成了6-氨基吡唑并[4,3 - c ]吡啶-4(5 H)-一(分别为18和22)的核糖呋喃糖基)-和2-(2-脱氧-β-D-核呋喃糖基)-衍生物。吡唑核苷前体的碱催化的闭环反应。甲基3(5)-cyanomethylpyrazole -4-羧酸乙酯(的钠盐的糖基化6与1-氯-2-脱氧-3,5-二- )ø - p甲苯甲酰-α-D-赤-pentofuranose(8)提供了相应的N-1和N-2糖基衍生物(分别为9和10)。用甲醇钠对9和10进行脱苯甲酰化,分别得到去保护的核苷14和16。14和16的进一步氨解得到5(或3)-氰基甲基-1-(2-脱氧-β-D-赤型-五呋喃糖基)吡唑-4-羧酰胺(分别为15和17)。在碳酸钠存在下15和17的闭环反应得到5和22, 分别。相比之下,钠盐的糖基化6与2
    DOI:
    10.1002/jhet.5570230112
点击查看最新优质反应信息

文献信息

  • Synthesis of β-D-ribo- and 2′-deoxy-β-D-ribofuranosyl derivatives of 6-aminopyrazolo[4,3-<i>c</i>]pyridin-4(5<i>H</i>)-one by a ring closure of pyrazole nucleoside precursors
    作者:Pranab K. Gupta、N. Kent Dalley、Roland K. Robins、Ganapathi R. Revankar
    DOI:10.1002/jhet.5570230112
    日期:1986.1
    and 17, respectively). Ring closure of 15 and 17 in the presence of sodium carbonate gave 5 and 22, respectively. By contrast, glycosylation of the sodium salt of 6 with 2,3,5-tri-O-benzoyl-D-ribofuranosyl bromide (11) or the persilylated 6 with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose gave mainly the N-2 glycosylated derivative 13, which on ammonolysis and ring closure furnished 18. Phosphorylation
    6-氨基-1-(2-脱氧-β-D-氨基-呋喃呋喃糖基)吡唑并[4,3 - c ]吡啶-4(5 H)-一(5)以及2-(β-D-合成了6-氨基吡唑并[4,3 - c ]吡啶-4(5 H)-一(分别为18和22)的核糖呋喃糖基)-和2-(2-脱氧-β-D-核呋喃糖基)-衍生物。吡唑核苷前体的碱催化的闭环反应。甲基3(5)-cyanomethylpyrazole -4-羧酸乙酯(的钠盐的糖基化6与1-氯-2-脱氧-3,5-二- )ø - p甲苯甲酰-α-D-赤-pentofuranose(8)提供了相应的N-1和N-2糖基衍生物(分别为9和10)。用甲醇钠对9和10进行脱苯甲酰化,分别得到去保护的核苷14和16。14和16的进一步氨解得到5(或3)-氰基甲基-1-(2-脱氧-β-D-赤型-五呋喃糖基)吡唑-4-羧酰胺(分别为15和17)。在碳酸钠存在下15和17的闭环反应得到5和22, 分别。相比之下,钠盐的糖基化6与2
查看更多

同类化合物

5-甲基-4-硝基-1-(β-D-呋喃核糖基)-1H-吡唑-3-甲酰胺 1-[(2R,3R,4S,5R)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]吡唑-3,4-二甲酰胺 1-β-D-ribofuranosylpyrazole 4-iodo-3-(3'-methyl-1',2',4'-oxadiazolyl)-1-β-D-ribofuranosylpyrazole 5-amino-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole-4-carboxamide 3,5-dimethyl-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole 4-phenylethynyl-1-β-D-ribofuranosylpyrazole-3-carboxamide 3,5-dimethyl-1-(α-D-arabinofuranosyl)pyrazole methyl 5-amino-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole-4-carboxylate ethyl 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-5-<(N'-ethoxycarbonylthiocarbamoyl)amino>pyrazole-4-carboxylate methyl 3-[5-amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-1H-pirazol-4-yl]-4,4,4-trifluoro-3-hydroxybutanoate 5-Amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-4-carboximidamide 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-(dimethylaminodiazenyl)pyrazole-4-carboxamide 3-Amino-1-pentofuranosyl-1h-pyrazole-4-carboxamide 5-Amino-1-pentofuranosyl-1h-pyrazole-4-carboxamide 1-(β-D-ribofuranosyl)pyrazole-4-carboxamide 1-(β-D-ribofuranosyl)pyrazole-4-thiocarboxamide 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carboxamide 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-bromo-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 2-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-3-carboxamide 1H-Pyrazole-3-carboxamide, 1-beta-D-ribofuranosyl- 1H-Pyrazolo-3-carboxamide, 4-amino-1-beta-D-ribofuranosyl- 1H-Pyrazole-5-carboxamide, 4-amino-1-beta-D-ribofuranosyl- 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-3,5-dicarboxamide 2-[5-amino-4-(1H-1,2,4-triazol-5-yl)pyrazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol Ethyl 2-[3,4-diacetyloxy-5-(acetyloxymethyl)oxolan-2-yl]-4-nitropyrazole-3-carboxylate 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-3-methyl-5-(methylthio)pyrazole methyl 4-phenylethynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate 3,5-dimethyl-1-(2,3,5-tri-O-benzyl-β-D-arabinofuranosyl)pyrazole methyl 4-propynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate 5-amino-1-(2',3'O-isopropylidene-β-D-ribofuranosyl)pyrazole-4-carboxamide 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-5-<(N'-benzoyl-S-methylisothiocarbamoyl)amino>pyrazole-4-carboxamide 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carboxamide methyl 4-iodo-1-β-D-ribofuranosyl-pyrazole-3-carboxylate 5-amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)pyrazole-4-carboxaldehyde 1-deoxy-1-N-pyrazolyl-2,3-O-isopropylidene-D-ribofuranose 1-(3,5-dimethyl-pyrazol-1-yl)-O2,O3-isopropylidene-D-1,4-anhydro-ribitol methyl 3-cyanomethyl-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)pyrazole-4-carboxylate 3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxamide methyl 3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxylate 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-5-(chloromethyl)pyrazole-3-carboxamide 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3-(chloromethyl)pyrazole-5-carboxamide 5-amino-1-(β-D-ribofuranosyl)-4-(imidazol-2-yl)pyrazole 4-iodo-1-β-D-ribofuranosylpyrazole-3-carboxamide